Mantu Gupta

Dr. Mantu Gupta


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2025 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
MGMantu Gupta
Mantu Gupta
ZSZiv Savin
Ziv Savin
DLDara J Lundon
Dara J Lundon
CCChristopher Connors
Christopher Connors
JSJuan Serna
Juan Serna
MGMantu Gupta
Mantu Gupta

17 January 2026 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
ZSZiv Savin
Ziv Savin
AGAdam Daniel Geffner
Adam Daniel Geffner
EFEve Frangopoulos
Eve Frangopoulos
VDVinay Durbhakula
Vinay Durbhakula
LRLinda Dayan Rahmani
Linda Dayan Rahmani
MGMantu Gupta
Mantu Gupta

11 September 2025 in Urolithiasis
Verified
Journal Article
Closed access
PDF file
ZSZiv Savin
Ziv Savin
MGMantu Gupta
Mantu Gupta
CCChristopher Connors
Christopher Connors
YEYuval Elkun
Yuval Elkun
EFEve Frangopoulos
Eve Frangopoulos
MGMantu Gupta
Mantu Gupta

24 March 2025 in Urolithiasis
Verified
Journal Article
Open access
PDF file
ABAndrewe L. Baca
Andrewe L. Baca
RPRutul D. Patel
Rutul D. Patel
KLKevin Labagnara
Kevin Labagnara
BGBenjamin Green
Benjamin Green
MZMichael Zhu
Michael Zhu
ASAlexander C. Small
Alexander C. Small
We aimed to characterize the underlying genetics of kidney stone disease (KSD) in an urban and diverse population using the Natera Renasight genetic panel. This was a single-center prospective study of high-risk KSD patients, defined as recurrent stone formers or those with a family history with KSD. Buccal saliva DNA samples were collected with the commercially available Natera Renasight genetic panel and were analyzed using next-generation sequencing. The panel assesses 385 kidney disease related genes, including 45 linked to KSD. One hundred eleven high-risk KSD patients were enrolled. The majority were female (56%) with a median age of 50 (IQR 39.5–59.5), compromising a diverse ethnic background with 62% Hispanic, 23% White and 11% Black. Patients had median 3 (IQR 2–5) lifetime stone episodes, and 41% had family history of KSD. Genetic analysis was possible for 105 patients (95%). Eight (8%) had positive tests with only one patient found to have a pathogenic mutation associated with KSD (SLC7A9, cystinuria). The other 7 positive tests included amyloidosis (TTR, N = 3), Alport syndrome (COL4A3, N = 2), polycystic kidney disease (PKD1, N = 1), and susceptibility to ESRD (APOL1, N = 1). Patients with positive tests were more likely to have chronic kidney disease (38% vs 5%, p < 0.01), gout (13% vs 1%, p = 0.02) and carbonate apatite stones (38% vs 7%, p < 0.01). Our study sheds light on genetic factors of KSD in a diverse patient population. The results suggest that KSD is unlikely monogenetic in nature, but is more likely due to a complex interplay of polygenetic and environmental influences. Genetic testing may be most useful in KSD patients with chronic kidney disease.

7 July 2025 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
CCChristopher Connors
Christopher Connors
MGMantu Gupta
Mantu Gupta
ZSZiv Savin
Ziv Savin
RKRaymond Khargi
Raymond Khargi
AGAdam Geffner
Adam Geffner
MGMantu Gupta
Mantu Gupta

12 March 2026 in World Journal of Urology
Verified
Journal Article
Open access
PDF file
ZSZiv Savin
Ziv Savin
AGAdam Daniel Geffner
Adam Daniel Geffner
EFEve Frangopoulos
Eve Frangopoulos
VDVinay Durbhakula
Vinay Durbhakula
LRLinda Dayan Rahmani
Linda Dayan Rahmani
MGMantu Gupta
Mantu Gupta